Profile Of Patients With Advanced Parkinson's disease Suitable For Device-Aided Therapies: Restrospective Data Of A Large Cohort Of Romanian Patients.

József Attila Szász Viorelia Adelina ConstantinKároly Orbán-KisAttila RáczLigia Ariana BancuDan GeorgescuJános SzederjesiIstván MihályAna-Mária FárrKrisztina KelemenTamás VajdaSzabolcs Szatmari

Published in: Neuropsychiatric disease and treatment (2019)

Patients with APD can have a variety of symptoms, and because symptoms and therapeutical efficacy can be manifested in many different combinations, it is not possible to decide using a single, rigid set of criteria which APD patient is eligible for DAT. Nevertheless, treating physicians should refer APD patients to a specialized movement disorder center when patients with an average daily dose of LD of at least 750-1000 mg and maximal complementary therapies present daily motor complications that significantly reduce the quality of life.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
primary care
machine learning
depressive symptoms
patient reported outcomes
heart rate
big data
sleep quality